POST-COVID ME/CFS

Clinical trials for POST-COVID ME/CFS explained in plain language.

Never miss a new study

Get alerted when new POST-COVID ME/CFS trials appear

Sign up with your email to follow new studies for POST-COVID ME/CFS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 2

Could a heart pill beat long COVID fatigue? new trial aims to find out.

Symptom relief Ongoing

This study tests whether the drug vericiguat, already approved for heart failure, can improve physical function and reduce fatigue in people aged 18-50 with post-COVID syndrome. About 104 participants will receive either vericiguat or a placebo for 10 weeks, then be followed for …

Matched conditions: POST-COVID ME/CFS

Phase: PHASE2 • Sponsor: Charite University, Berlin, Germany • Aim: Symptom relief

Last updated Jun 27, 2026 09:00 UTC

POST-COVID ME/CFS

Get alerted when new POST-COVID ME/CFS trials appear

Could a heart pill beat long COVID fatigue? new trial aims to find out.